Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: Madharry who wrote (258)	10/9/2001 9:14:07 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 724

Iliquid piece of garbage, almost managed into the ground. It's been a trap for those of us who have gone near it. Yeah, they're old, but their grandmother likes the ridiculous 10%/year stock dividend. Every modern bio lab needs ultralow freezers. It's a sweet spot. I don't know about the quality, as (1) they're produced by a British subsidiary, and (2) I left labs/biotech before NBSC started to sell them. Yes, they have a competitive advantage (small footprint), but I don't know if that advantage is backed by reliability. I recommend studying this TRAP for a good period of time before making any decision. Read the thread if you haven't done such, as there may be frosting (DGI) on this pile. Final comment..... I've been saying for quite some time that this company is worth $15/share. During the last big rally, insiders actually made tacky little sales. Report on bioterror coming up on CNBC. The need to prepare is real, and companies like NBSC should profit from it. But "should" is the operative word here, and this management team is rather frustrating.